|
165
|
Safety Signal of Bisoprolol and the Risk of Hyperkalaemia
|
|
Signal
|
|
|
164
|
Safety Signal of Dabigatran and the Risk of Acute Kidney Injury
|
|
Signal
|
|
|
163
|
Safety Signal of Nivolumab and the Risk of Capillary Leak Syndrome
|
|
Signal
|
|
|
162
|
Safety Signal of Testosterone and the Risk of Atrial Fibrillation
|
|
Signal
|
|
|
161
|
Safety Signal of Adalimumab and the Risk of Acute Febrile Neutrophilic Dermatosis
|
|
Signal
|
|
|
160
|
Safety Signal of Rivaroxaban and the Risk of Pemphigoid
|
|
Signal
|
|
|
159
|
Safety Signal of Encorafenib and the Risk of Tumour lysis syndrome
|
|
Signal
|
|
|
158
|
Safety Signal of ChAdOx1-S/nCoV-19 vaccine and the Risk of Pityriasis Rosea
|
|
Signal
|
|
|
157
|
Safety Signal of ChAdOx1-S/nCoV-19 vaccine and the Risk of Retinal vein occlusion
|
|
Signal
|
|
|
156
|
Safety Signal of ChAdOx1-S/nCoV-19 vaccine and the Risk of Myocardial infarction
|
|
Signal
|
|
